Incidence, Prevalence, and Mortality of Psychosis Associated with Parkinson's Disease (1991-2010)

被引:11
|
作者
Stang, Cole D. [1 ]
Mullan, Aidan F. [2 ]
Camerucci, Emanuele [1 ]
Hajeb, Mania [1 ]
Turcano, Pierpaolo [3 ]
Martin, Peter [2 ]
Mielke, Michelle M. [2 ]
Josephs, Keith A. [1 ]
Splett, Matthew [4 ]
Abler, Victor [4 ]
Boeve, Bradley F. [1 ]
Bower, James H. [1 ]
Savica, Rodolfo [1 ,2 ]
机构
[1] Mayo Clin, Dept Neurol, 200 First St,SW, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA
[3] Mayo Clin, Dept Neurol, Jacksonville, FL 32224 USA
[4] ACADIA Pharmaceut Inc, San Diego, CA USA
关键词
Parkinsonism; psychosis; hallucinations; delirium; antipsychotics; DRUG-INDUCED PSYCHOSIS; RECORDS-LINKAGE SYSTEM; DATA RESOURCE PROFILE; OLMSTED COUNTY; HALLUCINATIONS; POPULATION; CLOZAPINE; QUETIAPINE; SYMPTOMS; DEMENTIA;
D O I
10.3233/JPD-213035
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
BACKGROUND: Parkinson's disease (PD)-associated psychosis is a well-known non-motor complication, occurring years after diagnosis of PD. Incidence data vary across different studies highlighting a need for long-term observation and clinical definition. OBJECTIVE: To determine the incidence of psychosis in patients with PD and to investigate their survival in an incident cohort study from 1991-2010 in Olmsted County, MN. METHODS: We used the Rochester Epidemiology Project to define an incident-cohort study of parkinsonism (1991-2010) in Olmsted County, MN. A movement-disorder specialist reviewed the electronic medical records and applied diagnosis criteria to PD. Psychosis was diagnosed using of NINDS/NIMH unified criteria. RESULTS: We identified 669 cases of parkinsonism; 297 patients were clinically diagnosed with PD. 114/297 (38.4%) patients had evidence of psychosis (60% male); the median onset age of psychosis was 79.4 years. The incidence of Parkinson's disease psychosis (PDP) was 4.28/100 person-years. PDP patients had a 71% increased risk of death compared to PD patients. In PD patients without psychosis, men had 73.4% increased risk of death compared to women, whereas no significant sex difference was observed among PDP men vs. women. Of 114 patients diagnosed with psychosis, 59 were treated with antipsychotics. There was no significant difference in survival between treated and untreated patients. CONCLUSION: PDP increased the odds of death compared to PD patients. Men with PD without psychosis had greater odds of death compared to women; however, in PD with psychosis the odds of death were comparable among sexes. Lastly, treatment with anti-psychotics did not significantly affect survival.
引用
收藏
页码:1319 / 1327
页数:9
相关论文
共 50 条
  • [1] Parkinson's disease psychosis 2010 A review article
    Friedman, Joseph H.
    PARKINSONISM & RELATED DISORDERS, 2010, 16 (09) : 553 - 560
  • [2] A randomized controlled trial of quetiapine for psychosis in Parkinson's disease
    Shotbolt, Paul
    Samuel, Michael
    Fox, Chris
    David, Anthony S.
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2009, 5 : 327 - 332
  • [3] Treatment of Psychosis and Dementia in Parkinson's Disease
    Goldman, Jennifer G.
    Holden, Samantha
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2014, 16 (03)
  • [4] Treatment of Psychosis and Dementia in Parkinson’s Disease
    Jennifer G. Goldman
    Samantha Holden
    Current Treatment Options in Neurology, 2014, 16
  • [5] Management of Hallucinations and Psychosis in Parkinson's Disease
    Eng, Marty L.
    Welty, Timothy E.
    AMERICAN JOURNAL OF GERIATRIC PHARMACOTHERAPY, 2010, 8 (04) : 316 - 330
  • [6] Treating psychosis in people with Parkinson's disease
    Borek, Leora L.
    Friedman, Joseph H.
    EXPERT OPINION ON DRUG SAFETY, 2025, : 513 - 518
  • [7] Current Understanding of Psychosis in Parkinson's Disease
    Ojo, Oluwadamilola O.
    Fernandez, Hubert H.
    CURRENT PSYCHIATRY REPORTS, 2016, 18 (10)
  • [8] Novel pharmaceuticals in the treatment of psychosis in Parkinson's disease
    Broadstock, Martin
    Ballard, Clive
    Corbett, Anne
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2014, 7 (06) : 779 - 786
  • [9] An update expert opinion on management and research strategies in Parkinson's disease psychosis
    Goldman, Jennifer G.
    Vaughan, Christina L.
    Goetz, Christopher G.
    EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (13) : 2009 - 2024
  • [10] Pimavanserin: A Truly Effective Treatment for Parkinson's Disease Psychosis? A Review of Interventions
    Heim, Beatrice
    Peball, Marina
    Krismer, Florian
    Djamshidian, Atbin
    Seppi, Klaus
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2023, 19 : 1303 - 1312